SPY300.62-2.35 -0.78%
DIA252.03-2.32 -0.91%
IXIC9,327.51-41.48 -0.44%

Cantor Fitzgerald Assumes HTG Molecular Diagnostics at Overweight, Lowers Price Target to $1.5

Cantor Fitzgerald assumes HTG Molecular Diagnostics (NASDAQ:HTGM) with a Overweight rating and lowers Price Target to $1.5.

Benzinga · 05/11/2020 15:40

Cantor Fitzgerald assumes HTG Molecular Diagnostics (NASDAQ:HTGM) with a Overweight rating and lowers Price Target to $1.5.